Has Sonia Mehta, MD received payments from drug or device companies?

Yes. Drug and device makers reported $48,909 in general payments to Sonia Mehta, MD across 38 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sonia Mehta, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sonia Mehta, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sonia Mehta, MD

Ophthalmology · Plymouth Meeting, PANPI 1902004401

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $32,050 of the $48,909 with a category attached, or 65.5%. Astellas Pharma US Inc accounts for 72.5% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $28,503, more than ten times the $660 reported in 2019. Among ophthalmology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$48,909in general payments, 2019–2025

Across 38 payments — averaging $1287.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Astellas Pharma US Inc$35K
Genentech USA, Inc.$6K
Merck$5K
AbbVie$2K
Astellas Pharma Global Development$149
Alcon$130
plus $99 from 2 others

$393,311in research payments, 2019–2025

Across 27 payments — averaging $14,567 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Genentech, Inc.$393K

What the payments were for

Consulting fees$15,70532%
Speaking & faculty fees$32,05066%
Travel & lodging$320%
Food & beverage$1,1232%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Astellas Pharma US Inc	16	$35,443
Genentech USA, Inc.	6	$6,076
Merck	10	$5,390
AbbVie	2	$1,622
Astellas Pharma Global Development	1	$149
Alcon	1	$130
Apellis Pharmaceuticals, Inc.	1	$74
Novo Nordisk	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Izervay$35,560
VABYSMO$3,649
Lucentis$2,355
Clareon$130

How this compares

$48,909 in reported general payments places this provider in the 95th percentile of 920 ophthalmology providers in Pennsylvania.

See all ophthalmology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$7,094,428

Medicare patients

1,705

Services billed

61,277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	320	$19,632
ProlensaBromfenac Sodium	19	$6,562
IlevroNepafenac	13	$4,902
Ketorolac Tromethamine	164	$4,433
Bromfenac Sodium	15	$3,025
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	14	$2,430
Brimonidine Tartrate	23	$1,074
ValacyclovirValacyclovir Hcl	24	$968
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	41	$642
ErythromycinErythromycin Base	23	$229
Ofloxacin	15	$227
Dorzolamide Hcl	15	$226
Timolol Maleate	13	$93
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim	13	$69
Prednisone	15	$49

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Plymouth Meeting

Carl RegilloPlymouth Meeting$721K
Michael KlufasPlymouth Meeting$393K
Ajay KuriyanPlymouth Meeting$226K
Allen HoPlymouth Meeting$225K
Sunir GargPlymouth Meeting$216K
Yoshihiro YonekawaPlymouth Meeting$95K
Omesh GuptaPlymouth Meeting$85K
Julia HallerPhiladelphia$1.5M
Francis MahPittsburgh$1.1M
Brandon AyresBala Cynwyd$929K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →